» Articles » PMID: 27106930

PRDM14 Promotes RAG-dependent Notch1 Driver Mutations in Mouse T-ALL

Overview
Journal Biol Open
Specialty Biology
Date 2016 Apr 24
PMID 27106930
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

PRDM14 is an epigenetic regulator known for maintaining embryonic stem cell identity and resetting potency in primordial germ cells. However, hematopoietic expression of Prdm14 at supraphysiological levels results in fully penetrant and rapid-onset T-cell acute lymphoblastic leukemia (T-ALL) in the mouse. Here, we show that PRDM14-induced T-ALLs are driven by NOTCH1, a frequently mutated driver of human T-ALL. Notch1 is activated in this murine model via RAG-dependent promoter deletions and subsequent production of truncated, ligand-independent protein from downstream regions of the Notch1 locus. These T-ALLs also have focal changes in H3K4me3 deposition at the Notch1 locus and global increases in both H3K4me1 and H3K4me3. Using a PRDM14-FLAG mouse model, we show that PRDM14 binds within an intron of Notch1 prior to leukemia development. Our data support the idea that PRDM14 binding promotes a chromatin state that allows access of the RAG recombinase complex to cryptic RAG signal sequences embedded at the Notch1 locus. Indeed, breeding into a RAG recombination-deficient background abrogates T-ALL development and prevents Notch1 deletions, while allowing for transient hematopoietic stem cell (HSC)-like pre-leukemia cell expansion. Together, our data suggest that PRDM14 expands a progenitor cell population while promoting a permissive epigenetic state for the creation of driver mutations (here, in Notch1), enabling cancer development through the misappropriation of endogenous cellular DNA recombination machinery.

Citing Articles

Functional and molecular single-cell analyses implicate PRDM14 in the initiation of B cell leukemia in mice.

Tracey L, El-Maklizi M, Sokolowski D, Gams M, Brooke-Bisschop T, Ruston J Sci Rep. 2025; 15(1):8827.

PMID: 40087379 DOI: 10.1038/s41598-025-93043-z.


C-C Chemokine Receptor 7 Promotes T-Cell Acute Lymphoblastic Leukemia Invasion of the Central Nervous System via β2-Integrins.

Cardona C, Rodriguez A, Torres V, Sanchez A, Torres A, Vazquez A Int J Mol Sci. 2024; 25(17).

PMID: 39273598 PMC: 11395280. DOI: 10.3390/ijms25179649.


Therapeutic siRNA targeting the cancer cell stemness regulator PRDI-BF1 and RIZ domain zinc finger protein 14.

Imai K, Taniguchi H Proc Jpn Acad Ser B Phys Biol Sci. 2022; 98(7):325-335.

PMID: 35908955 PMC: 9363597. DOI: 10.2183/pjab.98.017.


The duality of PRDM proteins: epigenetic and structural perspectives.

Di Tullio F, Schwarz M, Zorgati H, Mzoughi S, Guccione E FEBS J. 2021; 289(5):1256-1275.

PMID: 33774927 PMC: 8979648. DOI: 10.1111/febs.15844.


Multifaceted Role of PRDM Proteins in Human Cancer.

Casamassimi A, Rienzo M, Di Zazzo E, Sorrentino A, Fiore D, Proto M Int J Mol Sci. 2020; 21(7).

PMID: 32290321 PMC: 7177584. DOI: 10.3390/ijms21072648.


References
1.
Witkowski M, Cimmino L, Hu Y, Trimarchi T, Tagoh H, McKenzie M . Activated Notch counteracts Ikaros tumor suppression in mouse and human T-cell acute lymphoblastic leukemia. Leukemia. 2015; 29(6):1301-11. PMC: 4845663. DOI: 10.1038/leu.2015.27. View

2.
Ma Z, Swigut T, Valouev A, Rada-Iglesias A, Wysocka J . Sequence-specific regulator Prdm14 safeguards mouse ESCs from entering extraembryonic endoderm fates. Nat Struct Mol Biol. 2010; 18(2):120-7. DOI: 10.1038/nsmb.2000. View

3.
Miosge L, Goodnow C . Genes, pathways and checkpoints in lymphocyte development and homeostasis. Immunol Cell Biol. 2005; 83(4):318-35. DOI: 10.1111/j.1440-1711.2005.01353.x. View

4.
Kelliher M, Seldin D, Leder P . Tal-1 induces T cell acute lymphoblastic leukemia accelerated by casein kinase IIalpha. EMBO J. 1996; 15(19):5160-6. PMC: 452259. View

5.
Pear W, Aster J, Scott M, Hasserjian R, Soffer B, Sklar J . Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles. J Exp Med. 1996; 183(5):2283-91. PMC: 2192581. DOI: 10.1084/jem.183.5.2283. View